Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.36 USD | -0.57% | 0.00% | +58.89% |
Financials (USD)
Sales 2024 * | 1B | Sales 2025 * | 1.17B | Capitalization | 748M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 29M | EV / Sales 2024 * | 0.98 x |
Net Debt 2024 * | 233M | Net Debt 2025 * | 463M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
55.9
x | P/E ratio 2025 * |
25.8
x | Employees | 1,920 |
Yield 2024 * |
2.6% | Yield 2025 * |
2.56% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | +0.27% | ||
1 week | +2.67% | ||
Current month | +10.54% | ||
1 month | +35.64% | ||
3 months | +43.32% | ||
6 months | +78.88% | ||
Current year | +59.41% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | Feb. 08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 25 M€ | -3.35% | - | |
0.32% | 28 M€ | -2.47% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 18.36 | -0.51% | 16 411 |
24-05-23 | 18.46 | +0.27% | 154,717 |
24-05-22 | 18.41 | +0.22% | 88,744 |
24-05-21 | 18.37 | +0.77% | 101,730 |
24-05-20 | 18.23 | -0.92% | 108,624 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.41% | 748M | |
-13.41% | 77.98B | |
+10.67% | 8.15B | |
+23.38% | 3.66B | |
-3.71% | 1.6B | |
+14.02% | 1.63B | |
-21.59% | 1.31B | |
+2.54% | 1.34B | |
-9.96% | 1.18B | |
+2.78% | 1.11B |
- Stock Market
- Equities
- PAHC Stock